NCT04897490View on ClinicalTrials.gov

RWE of 1st Line Treatment With ATO/ATRA for Adult APL

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

July 1, 2026

Study Completion Date

December 31, 2026

Conditions
Promyelocytic Leukemia, Adult Acute
Interventions
OTHER

Evaluation of first line treatment with ATO/ATRA outcome

Evaluation of first line treatment with ATO/ATRA outcome (o event free survival and overall survival and toxicity) in adult patients with APL.

Trial Locations (6)

Unknown

RECRUITING

Hospital Italiano de La Plata, La Plata

RECRUITING

Instituto Privado de Hematologia y Hemoterapia, Paraná

RECRUITING

Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas

RECRUITING

Hospital Descentralizado Dr. Guillermo Rawson, Rawson

RECRUITING

CEMIC, CABA

RECRUITING

FUNDALEU, CABA

All Listed Sponsors
lead

Grupo Argentino de Tratamiento de la Leucemia Aguda

OTHER